Similarly, Murphy et al. [224] reported the correlation of CXCL8, CXCR1, and CXCR2 expression in prostate cancer with advancing disease stage and its ability in promotion angiogenesis. This evidence concerns the gene CXCR2 and prostate carcinoma.